Evanthia Triantafylou-Bernitsas, MD joined the Department of Neurology at Wayne State University in 2011. She is a board certified Neurologist and a Multiple Sclerosis specialist. Currently, she serves as Assistant Professor of Neurology and Associate Director of the Multiple Sclerosis Center at Wayne State School of Medicine.
Her clinical and research interests include tremor in MS, epilepsy and MS, clinical management of MS and MS variants. She is the PI and co-PI in multiple MS -related clinical trials. She is actively involved in medical students� and neurology residents� education.
Aristotelian Medical School, Thessaloniki, Greece, MD, 1990
Partners, St. Vincent Hospital, Toledo, OH, 2004-2005
- AHEPA/Theagenion Hospital, Thessaloniki, Greece, 1990-1993
- Mercy Health Partners, Toledo, OH, 2004-2005
- Case Western Reserve University, University Hospitals of Cleveland, Cleveland, OH, 2005-2008
- Walter Reed Army Medical Center, NIH/USUHS, Research Fellow, Bethesda, MR, 1993-1995
- University of Michigan, Neuroscience Research, Ann Arbor, MI, 2000-2001
- University of Michigan, Neurorology Research, Ann Arbor, MI, 2001-2004 Maxine Mesinger Comprehensive MS Center, Baylor College of Medicine, Multiple Sclerosis, Houston, TX, 2008-2009
University of Michigan, Assistant Professor, 2009-2011
- MS and epilepsy
- Intractable tremor in MS and deep brain stimulation (DBS)
- RLS: pathophysiology and treatment, movement disorders
Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW, and the CAMMS 223 Study Investigators (Bernitsas E, Member and Co-I). Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial. Neurology 2012;78:1069-1078
Lindsey J, Scott T, Lynch S, Cofield S, Nelson F, Conwit R, and the CombiRx Investigators Group (Bernitsas, E Member and Co-I). The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics. Mult Scler Relat Disord. 2012;1: 81-86
Bernitsas E. Clinical Neuroimmunology: MS and related disorders. Book review. Journal of Neurological Sciences, V320, issue 1, p169, 15 September 2012
Bernitsas E, Wei W, Mikol, DD: Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane. Annals of Neurology. 59 (1), 206-209, 2006.
2012-2013 Best Doctors in America and in Michigan
MS Clinical Fellowship Award, National MS Society, 2008-2009